Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15124675

Download in:

View as

General Info

PMID
15124675